SEC Form 4 · accession 0001967360-26-000008
Legend Biotech Corp · LEGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ying Huang
Officer — Chief Executive Officer · Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001801198
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 30, 2026 | G | 3,382 | $0.00 | D | 238,490 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
- F2Represents a bone fide gift to a charitable organization.